Back to top

Image: Bigstock

Is Novartis (NVS) Outperforming Other Medical Stocks This Year?

Read MoreHide Full Article

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Novartis (NVS - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

Novartis is a member of the Medical sector. This group includes 915 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Novartis is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for NVS' full-year earnings has moved 2.8% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Our latest available data shows that NVS has returned about 16.4% since the start of the calendar year. In comparison, Medical companies have returned an average of 10%. As we can see, Novartis is performing better than its sector in the calendar year.

Another Medical stock, which has outperformed the sector so far this year, is Alpha Cognition Inc. (ACOG - Free Report) . The stock has returned 27.7% year-to-date.

Over the past three months, Alpha Cognition Inc.'s consensus EPS estimate for the current year has increased 3.3%. The stock currently has a Zacks Rank #2 (Buy).

To break things down more, Novartis belongs to the Large Cap Pharmaceuticals industry, a group that includes 11 individual companies and currently sits at #73 in the Zacks Industry Rank. Stocks in this group have gained about 26.6% so far this year, so NVS is slightly underperforming its industry this group in terms of year-to-date returns.

Alpha Cognition Inc., however, belongs to the Medical - Biomedical and Genetics industry. Currently, this 449-stock industry is ranked #87. The industry has moved +8.2% so far this year.

Investors interested in the Medical sector may want to keep a close eye on Novartis and Alpha Cognition Inc. as they attempt to continue their solid performance.

Published in